But the GHRH + GHRP synergy principle is well-established, the individual compounds are well-characterized, and the real-world results from myself and thousands of users are consistently impressive
However, in the case of cardiovascular indications, Wegovy seems to have the upper hand, as Zepbound hasnt demonstrated cardiovascular benefit yet
This gives food companies a chance to meet new needs, as the more people get on this drug, the more people will want foods with more nutrients and fewer calories, especially better protein supplements
Martinotti, G., Reina, D., Di, Nicola M., Andreoli, S., Tedeschi, D., Ortolani, I., Pozzi, G., Iannoni, E., D'Iddio, S., and Janiri, L
Research suggests yes through direct effects on inflammatory pathways, gut health, insulin resistance, and oxidative stress that don't depend on losing weight, which is part of why low-dose "microdosing" can help